Variant report
Variant | esv3471972 |
---|---|
Chromosome Location | chr6:167487999-167489840 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:167487932..167489942-chr6:167492963..167495055,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543186374 | chr6:167488000-167488001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558610603 | chr6:167488007-167488008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs377523939 | chr6:167488043-167488044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs201646222 | chr6:167488071-167488072 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531796472 | chr6:167488185-167488186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188333243 | chr6:167488275-167488276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs180700892 | chr6:167488283-167488284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546425750 | chr6:167488296-167488297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550116558 | chr6:167488321-167488322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530439327 | chr6:167488502-167488503 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs149243372 | chr6:167488762-167488763 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564488301 | chr6:167488773-167488774 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571461222 | chr6:167488792-167488793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144846438 | chr6:167488858-167488859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9459863 | chr6:167488881-167488882 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs528539962 | chr6:167488918-167488919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532255770 | chr6:167488960-167488961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547202396 | chr6:167488961-167488962 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370776070 | chr6:167488973-167488974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187411180 | chr6:167489042-167489043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140142902 | chr6:167489105-167489106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554425458 | chr6:167489230-167489231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550381630 | chr6:167489312-167489313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs204299 | chr6:167489316-167489317 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs192256171 | chr6:167489415-167489416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558220353 | chr6:167489434-167489435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576880621 | chr6:167489471-167489472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534393031 | chr6:167489531-167489532 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs149263102 | chr6:167489542-167489543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71678149 | chr6:167489543-167489544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs9366087 | chr6:167489571-167489572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201268164 | chr6:167489575-167489576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs370355749 | chr6:167489576-167489577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9356555 | chr6:167489593-167489594 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553631662 | chr6:167489601-167489602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs9366088 | chr6:167489603-167489604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs71571476 | chr6:167489696-167489697 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs376720393 | chr6:167489701-167489702 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs202218150 | chr6:167489721-167489722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368265395 | chr6:167489722-167489723 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs9348222 | chr6:167489735-167489736 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145580077 | chr6:167489751-167489752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566433139 | chr6:167489793-167489794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542586027 | chr6:167489794-167489795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73039135 | chr6:167489806-167489807 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Developmental delay | 21147756 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:167487000-167494400 | Enhancers | Primary B cells from peripheral blood | blood |
2 | chr6:167487400-167489000 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |
3 | chr6:167487400-167492600 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
4 | chr6:167487600-167489800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr6:167487600-167492400 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
6 | chr6:167487800-167488200 | Weak transcription | Primary B cells from cord blood | blood |
7 | chr6:167488200-167488400 | Enhancers | Primary B cells from cord blood | blood |
8 | chr6:167488400-167491000 | Weak transcription | Primary B cells from cord blood | blood |
9 | chr6:167489000-167489200 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
10 | chr6:167489200-167492200 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |
11 | chr6:167489800-167490200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |